Related Experiment Video
Updated: Jan 23, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy
Marie Besnier1, Saran Shantikumar1, Maryam Anwar2
1Bristol Heart Institute, University of Bristol, Bristol, UK.
Abstract:
MicroRNA-15a (miR-15a) and miR-16, which are transcribed from the miR-15a/miR-16-1 cluster, inhibit post-ischemic angiogenesis. MicroRNA (miRNA) binding to mRNA coding sequences (CDSs) is a newly emerging mechanism of gene expression regulation. We aimed to (1) identify new mediators of the anti-angiogenic action of miR-15a and -16, (2) develop an adenovirus (Ad)-based miR-15a/16 decoy system carrying a luciferase reporter (Luc) to both sense and inhibit miR-15a/16 activity, and (3) investigate Ad.Luc-Decoy-15a/16 therapeutic potential in a mouse limb ischemia (LI) model. LI increased miR-15a and -16 expression in mouse muscular endothelial cells (ECs). The miRNAs also increased in cultured human umbilical vein ECs (HUVECs) exposed to serum starvation, but not hypoxia. Using bioinformatic tools and luciferase activity assays, we characterized miR-15a and -16 binding to Tie2 CDS. In HUVECs, miR-15a or -16 overexpression reduced Tie2 at the protein, but not the mRNA, level. Conversely, miR-15a or -16 inhibition improved angiogenesis in a Tie2-dependent manner. Local Ad.Luc-Decoy-15a/16 delivery increased Tie2 levels in ischemic skeletal muscle and improved post-LI angiogenesis and perfusion recovery, with reduced toe necrosis. Bioluminescent imaging (in vivo imaging system [IVIS]) provided evidence that the Ad.Luc-Decoy-15a/16 system responds to miR-15a/16 increases. In conclusion, we have provided novel mechanistic evidence of the therapeutic potential of local miR-15a/16 inhibition in LI.
Insights
MicroRNA-15a (miR-15a) and miR-16 inhibit blood vessel formation after ischemia. A novel decoy system targeting these microRNAs improved blood flow and tissue recovery in a mouse limb ischemia model.
Area of Science:
- Molecular Biology
- Cardiovascular Biology
- Gene Regulation
Background:
- MicroRNA-15a (miR-15a) and miR-16 are known to inhibit post-ischemic angiogenesis.
- MicroRNA (miRNA) binding to messenger RNA (mRNA) coding sequences (CDSs) is a key gene expression regulatory mechanism.
Purpose of the Study:
- Identify novel mediators of miR-15a/16 anti-angiogenic effects.
- Develop an adenovirus (Ad)-based system to sense and inhibit miR-15a/16 activity.
- Evaluate the therapeutic potential of this decoy system in a mouse limb ischemia (LI) model.
Main Methods:
- Utilized bioinformatic tools and luciferase assays to identify miR-15a/16 targets.
- Overexpressed and inhibited miR-15a/16 in cultured endothelial cells (ECs).
- Delivered an Ad-based miR-15a/16 decoy system (Ad.Luc-Decoy-15a/16) locally in a mouse LI model and assessed outcomes using bioluminescent imaging.
Main Results:
- miR-15a and miR-16 expression increased in ECs during limb ischemia and serum starvation.
- miR-15a/16 directly bind to the Tie2 coding sequence, reducing Tie2 protein levels.
- Inhibition of miR-15a/16 enhanced angiogenesis in a Tie2-dependent manner.
- Local delivery of Ad.Luc-Decoy-15a/16 restored Tie2 levels, improved angiogenesis, perfusion, and reduced necrosis in the mouse LI model.
- Bioluminescent imaging confirmed the Ad.Luc-Decoy-15a/16 system's responsiveness to elevated miR-15a/16.
Conclusions:
- Novel mechanistic insight into miR-15a/16-mediated inhibition of angiogenesis via Tie2.
- Demonstrated the therapeutic efficacy of targeting miR-15a/16 using a decoy system for limb ischemia.
- Established a responsive bioluminescent reporter system for monitoring miR-15a/16 activity in vivo.
Related Concept Videos
Cattell's 16 Personality Factors
In contrast, source traits are the...
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Cis-regulatory Sequences
Feedback Inhibition
Nursing Code of Ethics

